| Original language | English (US) |
|---|---|
| Pages (from-to) | 697-705 |
| Number of pages | 9 |
| Journal | Gastroenterology |
| Volume | 159 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 2020 |
Bibliographical note
Funding Information:Conflicts of interest These authors disclose the following: Premysl Bercik received financial support/remuneration from Nestex, Allergan Canada, IM HealthScience, and LUPIN Pharma Canada. Adam V. Weizman received financial support/renumeration from AbbVie, Janssen Pharmaceutica, Takeda Pharmaceutical Company, and Ferring Pharmaceuticals. The remaining authors disclose no conflicts. All members were required to complete disclosure statement. These statements are maintained at the American Gastroenterological Association Institute headquarters in Bethesda, Maryland and pertinent disclosures are published with the report.